By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GI Dynamics 

Boston  Massachusetts    U.S.A.
Phone: 617-454-6025 Fax:


Medical Device

Company News
GI Dynamics (GID.AX) Release: Meta-Analysis Show Endobarrier Improves Glycemic Control, Induces Weight Loss In Patients With Type 2 Diabetes And Obesity 5/23/2017 5:26:24 AM
GI Dynamics (GID.AX) Announces EndoBarrier CE Mark Suspension 5/18/2017 10:23:32 AM
GI Dynamics (GID.AX) Announces Access to 2017 Annual Meeting Of Stockholders And Corporate Update 5/18/2017 10:21:41 AM
GI Dynamics (GID.AX) Selects Allenby Capital To Explore AIM Listing Option 5/3/2017 9:22:53 AM
GI Dynamics (GID.AX) To Release 2016 Annual Report And Host Webcast For Year Ending 31 December 2016 3/23/2017 6:32:08 AM
GI Dynamics (GID.AX) Announces Scientific Advisory Board Members To Further Scientific Understanding Of EndoBarrier 3/13/2017 8:29:29 AM
GI Dynamics (GID.AX) Announces New Scientific Advisory Board And Board’s First Two Members 3/7/2017 6:54:05 AM
GI Dynamics (GID.AX) Shows Off Prelim Endobarrier Data in Adolescent Prediabetes Treatment 2/16/2017 9:39:51 AM
GI Dynamics (GID.AX) Release: EndoBarrier Receives German NUB Reimbursement Status 1 For Type 2 Diabetes And Obesity Therapy 2/1/2017 10:38:32 AM
GI Dynamics (GID.AX) Release: Medical Device Firm Provides 2017 Business Outlook And 2016 Review 1/11/2017 7:50:22 AM